Skip to content

Effects of transcranial magnetic stimulation combined with visual conflict task training on anxiety and depression after stroke under specific mode

Effects of transcranial magnetic stimulation combined with visual conflict task training on anxiety and depression after stroke under specific mode

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058553
Enrollment
Unknown
Registered
2022-04-10
Start date
2022-03-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular disease

Interventions

Group A:Transcranial magnetic stimulation (TMS)
Group B:Visual conflict task training
Group C:Transcranial magnetic stimulation + visual conflict task training
Group D:Routine rehabilitation training

Sponsors

The Second Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. The first stroke 6 months; 2. Aged >=18 years and 4, NIHSS=2; 6. Complete CT or MRI; 7. No serious neurological or mental illness; Unconsciousness disorder, can cooperate with the relevant treatment; No significant cognitive impairment (MMSE>=15 points); 8. Any depressive disorder that meets the diagnostic criteria of the DSM-V; 9. Right-handed; 10. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe comorbidities; 2. Drug use history: benzodiazepines, baclofen, antidepressants; 3. Those who do not adhere to the program; 4. Acute stage of cerebral hemorrhage, acute infectious disease; 5. There is a strong suicidal tendency in depression; 6. Severe headache, high blood pressure, malignant tumor, open wound, vascular embolism, leukocytosis and other patients; 7. Serious alcohol abusers; 8. Patients with a history of craniocerebral surgery and metal implants in the brain; 9. Patients with cardiac pacemaker implantation; 10. Any disease that may cause the patient to fail to survive for more than 1 month; 11. Pregnant patients.

Design outcomes

Primary

MeasureTime frame
Neuropsychological scale;EEG data;MRI data;

Countries

China

Contacts

Public ContactYao Liqing
yaoliqing98731@163.com+86 13529202383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026